Lara Longpre, CHIEF DEVELOPMENT OFFICER at Mirum Pharmaceuticals, Inc. (MIRM), bought 965 shares at $10.64 ($10K) on 2019-09-10, disclosed to the SEC on 2024-03-18.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.
| Filing → |
| MIRM | SELL | 2023-07-05 | $26K | — | Filing → |
| MIRM | SELL | 2021-10-01 | $19K | — | Filing → |